Literature DB >> 30720158

MiR-374b reduces cell proliferation and cell invasion of cervical cancer through regulating FOXM1.

N Xia1, W-F Tan, Q-Z Peng, H-N Cai.   

Abstract

OBJECTIVE: Deregulation of microRNAs (miRNAs) has been identified as critical event in tumor initiation and progression. We aimed to explore the role of miR-374b in cervical cancer progression. PATIENTS AND METHODS: MiR-374b expression was detected using qRT-PCR in cervical cancer tissues compared with normal counterparts. Cell proliferation and invasion ability were detected using Cell Counting Kit-8 (CCK8) cell proliferation and transwell invasion assay. Dual luciferase reporter assay, qRT-PCR, and Western blot analysis were used to demonstrate that FOXM1 was a target of miR-374b.
RESULTS: We demonstrated that downregulation of miR-374b was frequently examined in cervical cancer tissues compared with normal counterparts. Furthermore, we showed the lower miR-374b expression associated with lymph node metastasis and advanced FIGO stage in patients with cervical cancer. Furthermore, ectopic expression of miR-374b could significantly decrease cell proliferation and invasion ability. However, inhibition of miR-374b had opposite effects. Dual luciferase reporter assay, qRT-PCR, and Western blot analysis revealed that miR-374b overexpression suppressed cell proliferation and invasion ability via affecting FOXM1 expression.
CONCLUSIONS: These results indicated that miR-374b acted as tumor suppressor and may serve as a potential target for cervical cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30720158     DOI: 10.26355/eurrev_201901_16863

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.

Authors:  Ke Fu; Ling Zhang; Rui Liu; Qi Shi; Xue Li; Min Wang
Journal:  World J Surg Oncol       Date:  2020-05-30       Impact factor: 2.754

2.  MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.

Authors:  Xu Chen; Ruiqin Cao; Haifang Liu; Tuanying Zhang; Xinrong Yuan; Shuxiang Xu
Journal:  Int J Mol Med       Date:  2020-08-12       Impact factor: 4.101

3.  Oncogenic and tumor suppressor function of MEIS and associated factors.

Authors:  Birkan Gİrgİn; Medine KaradaĞ-Alpaslan; Fatih KocabaŞ
Journal:  Turk J Biol       Date:  2020-12-14

4.  CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1.

Authors:  Shufeng Li; Ning Liu; Jinxia Piao; Fanxu Meng; Yanyan Li
Journal:  Onco Targets Ther       Date:  2020-12-01       Impact factor: 4.345

5.  LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis.

Authors:  Bolong Yi; Hao Li; Heng Cai; Xin Lou; Mingjun Yu; Zhen Li
Journal:  J Cell Mol Med       Date:  2021-12-08       Impact factor: 5.310

6.  Urushiol V Suppresses Cell Proliferation and Enhances Antitumor Activity of 5-FU in Human Colon Cancer Cells by Downregulating FoxM1.

Authors:  Ji Hye Jeong; Jae-Ha Ryu
Journal:  Biomol Ther (Seoul)       Date:  2022-05-01       Impact factor: 4.634

Review 7.  Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review.

Authors:  Guojuan Sun; Qiang Zhang; Yi Liu; Ping Xie
Journal:  Appl Bionics Biomech       Date:  2022-08-21       Impact factor: 1.664

Review 8.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.